telmisartan has been researched along with Allodynia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuohashish, HM; Ahmed, MM; Al-Rejaie, SS; Aleisa, AM; AlSharari, SD; Arrejaie, AS | 1 |
| Jaggi, AS; Singh, N | 1 |
2 other study(ies) available for telmisartan and Allodynia
| Article | Year |
|---|---|
Telmisartan inhibits hyperalgesia and inflammatory progression in a diabetic neuropathic pain model of Wistar rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cytokines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperalgesia; Inflammation; Male; Motor Activity; Pain Measurement; Physical Stimulation; Rats; Rats, Wistar; Sciatic Nerve; Telmisartan | 2015 |
Exploring the potential of telmisartan in chronic constriction injury-induced neuropathic pain in rats.
Topics: Animals; Behavior, Animal; Benzimidazoles; Benzoates; Constriction, Pathologic; Female; Foot Deformities; Hyperalgesia; Male; Neuralgia; Rats; Rats, Wistar; Telmisartan; Tumor Necrosis Factor-alpha | 2011 |